EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lactylation in urological malignancies: emerging mechanisms and therapeutic direction

Jiafeng Lin, Chenye Yuan, Chunsheng Liu, Minjie Zhang, Jianbin Luo, Zhihuang Wu, Qinghong Ma, Shengbiao Xie, Yufeng Liang, Guoqiang Chen

Frontiers in Cell and Developmental Biology · 12.02.2026 · 14

DOI: 10.3389/fcell.2026.1764134 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 12.02.2026. Verfasst von Jiafeng Lin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Hospital of Longyan, Longyan, Fujian, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Urological malignancies represent a group of highly aggressive tumors with a strong tendency toward therapy resistance. Their pathogenesis is closely associated with metabolic reprogramming and epigenetic regulation. In recent years, lactylation, a novel form of post-translational modification, has garnered significant attention due to its crucial role in linking cellular metabolism with epigenetics. By covalently modifying lysine residues on both histone and non-histone proteins, lactylation dynamically regulates gene transcription and protein function, thereby influencing malignant behaviors in urological malignancies—including proliferation, metastasis, immune evasion, and therapeutic resistance. This review begins by systematically outlining the fundamental characteristics of lactylation and its regulatory networks. It then summarizes the general roles of lactylation in cancer, with a particular emphasis on its mechanisms and functional implications in urological malignancies. Finally, we discuss current research challenges and future directions, aiming to provide new insights into the metabolic–epigenetic interplay in urological malignancies and to establish a theoretical foundation for targeting lactylation as a potential therapeutic strategy and prognostic biomarker.

Schlagwörter

Stichwörter der Autor:innen

bladder cancerdrug resistanceimmunitylactylationprostate cancerrenal cell carcinoma

Autor:innen und Institutionen

  • Department of Urology, The Second Hospital of Longyan, Longyan, Fujian, China.
  • The Fourth Clinical College, China Medical University, Shenyang, Liaoning, China.
  • Department of Nephrology, The Second Hospital of Longyan, Longyan, Fujian, China.

Zitieren

APA

Lin, J., Yuan, C., Liu, C., Zhang, M., Luo, J., Wu, Z., Ma, Q., Xie, S., Liang, Y., & Chen, G. (2026). Lactylation in urological malignancies: emerging mechanisms and therapeutic direction. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1764134

Vancouver

Lin J, Yuan C, Liu C, Zhang M, Luo J, Wu Z, et al. Lactylation in urological malignancies: emerging mechanisms and therapeutic direction. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1764134

BibTeX
@article{Lin2026,
  author = {Lin, Jiafeng and Yuan, Chenye and Liu, Chunsheng and Zhang, Minjie and Luo, Jianbin and Wu, Zhihuang and Ma, Qinghong and Xie, Shengbiao and Liang, Yufeng and Chen, Guoqiang},
  title = {Lactylation in urological malignancies: emerging mechanisms and therapeutic direction},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2026},
  volume = {14},
  doi = {10.3389/fcell.2026.1764134}
}
Kostenlos starten →